57 related articles for article (PubMed ID: 24184213)
1. Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).
Juvale K; Gallus J; Wiese M
Bioorg Med Chem; 2013 Dec; 21(24):7858-73. PubMed ID: 24184213
[TBL] [Abstract][Full Text] [Related]
2. Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position.
Winter E; Gozzi GJ; Chiaradia-Delatorre LD; Daflon-Yunes N; Terreux R; Gauthier C; Mascarello A; Leal PC; Cadena SM; Yunes RA; Nunes RJ; Creczynski-Pasa TB; Di Pietro A
Drug Des Devel Ther; 2014; 8():609-19. PubMed ID: 24920885
[TBL] [Abstract][Full Text] [Related]
3. Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
Valdameri G; Gauthier C; Terreux R; Kachadourian R; Day BJ; Winnischofer SM; Rocha ME; Frachet V; Ronot X; Di Pietro A; Boumendjel A
J Med Chem; 2012 Apr; 55(7):3193-200. PubMed ID: 22449016
[TBL] [Abstract][Full Text] [Related]
4. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
Natarajan K; Xie Y; Baer MR; Ross DD
Biochem Pharmacol; 2012 Apr; 83(8):1084-103. PubMed ID: 22248732
[TBL] [Abstract][Full Text] [Related]
5. Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2).
da Silva Zanzarini I; Henrique Kita D; Scheiffer G; Karoline Dos Santos K; de Paula Dutra J; Augusto Pastore M; Gomes de Moraes Rego F; Picheth G; Ambudkar SV; Pulvirenti L; Cardullo N; Rotuno Moure V; Muccilli V; Tringali C; Valdameri G
Bioorg Chem; 2024 May; 146():107283. PubMed ID: 38513324
[TBL] [Abstract][Full Text] [Related]
6. Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors.
Zhu J; Lei S; Lu J; Hao Y; Qian Q; Devanathan AS; Feng Z; Xie XQ; Wipf P; Ma X
Eur J Med Chem; 2023 Nov; 259():115666. PubMed ID: 37482017
[TBL] [Abstract][Full Text] [Related]
7. High-throughput BCRP inhibitors screening system based on styrene maleic acid polymer membrane protein stabilization strategy and surface plasmon resonance biosensor.
Fang J; Shen S; Wang H; He Y; Chao L; Cao Y; Chen X; Zhu Z; Hong Z; Chai Y
Talanta; 2024 Jul; 274():125987. PubMed ID: 38552478
[TBL] [Abstract][Full Text] [Related]
8. One-step synthesis of diaryloxadiazoles as potent inhibitors of BCRP.
Yi W; Tran-Nguyen VK; Boumendjel A
Future Med Chem; 2024 Apr; ():. PubMed ID: 38573062
[No Abstract] [Full Text] [Related]
9. Quinazoline Derivatives as Potential Therapeutic Agents in Urinary Bladder Cancer Therapy.
Wdowiak P; Matysiak J; Kuszta P; Czarnek K; Niezabitowska E; Baj T
Front Chem; 2021; 9():765552. PubMed ID: 34805097
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2).
Krapf MK; Gallus J; Wiese M
Eur J Med Chem; 2017 Oct; 139():587-611. PubMed ID: 28841513
[TBL] [Abstract][Full Text] [Related]
11. Design of inhibitors of BCRP/ABCG2.
Juvale K; Wiese M
Future Med Chem; 2015 Aug; 7(12):1521-7. PubMed ID: 26293476
[TBL] [Abstract][Full Text] [Related]
12. ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy.
Cui H; Zhang AJ; Chen M; Liu JJ
Curr Drug Targets; 2015; 16(12):1356-71. PubMed ID: 25901528
[TBL] [Abstract][Full Text] [Related]
13. The More the Better-Investigation of Polymethoxylated
Stockmann P; Kuhnert L; Leinung W; Lakoma C; Scholz B; Paskas S; Mijatović S; Maksimović-Ivanić D; Honscha W; Hey-Hawkins E
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678870
[TBL] [Abstract][Full Text] [Related]
14. A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors.
Stefan SM; Jansson PJ; Pahnke J; Namasivayam V
Sci Data; 2022 Jul; 9(1):446. PubMed ID: 35882865
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.
Dei S; Braconi L; Romanelli MN; Teodori E
Cancer Drug Resist; 2019; 2(3):710-743. PubMed ID: 35582565
[TBL] [Abstract][Full Text] [Related]
16. Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA).
Namasivayam V; Silbermann K; Pahnke J; Wiese M; Stefan SM
Comput Struct Biotechnol J; 2021; 19():3269-3283. PubMed ID: 34141145
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach.
Le MT; Hoang VN; Nguyen DN; Bui TH; Phan TV; Huynh PN; Tran TD; Thai KM
Molecules; 2021 May; 26(11):. PubMed ID: 34071039
[TBL] [Abstract][Full Text] [Related]
18. C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors.
Namasivayam V; Silbermann K; Wiese M; Pahnke J; Stefan SM
J Med Chem; 2021 Mar; 64(6):3350-3366. PubMed ID: 33724808
[TBL] [Abstract][Full Text] [Related]
19. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.
Jiang D; Lei T; Wang Z; Shen C; Cao D; Hou T
J Cheminform; 2020 Mar; 12(1):16. PubMed ID: 33430990
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen Transfer-Mediated Multicomponent Reaction for Direct Synthesis of Quinazolines by a Naphthyridine-Based Iridium Catalyst.
Tan Z; Fu Z; Yang J; Wu Y; Cao L; Jiang H; Li J; Zhang M
iScience; 2020 Apr; 23(4):101003. PubMed ID: 32278286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
